← Eichor
Study identifier: NCT05250375 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Natural History Study of Mitochondrial Myopathy

Condition: Primary Mitochondrial Disease  ·  Sponsor: Children's Hospital of Philadelphia

PhaseN/A
Planned participants1300
Who can joinAll sexes, 0 Years to 100 Years
Healthy volunteersYes

About this study

The goal of this observational study is to develop and validate tools to measure disease course in patients with primary mitochondrial myopathy (PMM). The main aims of this study are: * Development, validation, and optimization of objective outcome measures for mitochondrial myopathy * Defining the natural history of mitochondrial myopathy Researchers will compare data from patients with primary mitochondrial myopathy to healthy controls. Data from healthy controls will also help define normative data for future studies. Participants will perform clinical exams of muscle strength and endurance and will complete surveys.

This description comes directly from the study's public registry record.

Talk to the study team

Katelynn Stanley, BS  ·  267 426 4961  ·  MitochondrialMyopathyResearch@chop.edu

Jean Flickinger, PT  ·  267 426 4961  ·  MitochondrialMyopathyResearch@chop.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05250375